New stroke drug shows promise in clinical trial
NCT ID NCT05403866
Summary
This study tested an experimental drug called LT3001 for people who recently had an ischemic stroke (caused by a blood clot). Researchers compared LT3001 against a placebo in 89 patients to see if it was safe and could help improve recovery. The drug was given within 24 hours of stroke symptoms starting, alongside standard medical care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chattanooga Center for Neurologic Research
Chattanooga, Tennessee, 37403, United States
Conditions
Explore the condition pages connected to this study.